Server:Apache...
X-Powered-By:W3 Total Cache/0.9.6
The main IP address: 89.187.86.121,Your server United Kingdom,London ISP:Coreix Customer Block TLD:com CountryCode:GB
The description :contact : [email protected] about us technology pipeline competitive advantages news & events contact us enter search words and press enter oral administration triggers broad immunity thermostabl...
This report updates in 25-Jul-2018
Created Date: | 2009-09-08 |
Changed Date: | 2017-09-03 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host prokarium.com. Currently, hosted in United Kingdom and its service provider is Coreix Customer Block .
Latitude: | 51.508529663086 |
Longitude: | -0.12574000656605 |
Country: | United Kingdom (GB) |
City: | London |
Region: | England |
ISP: | Coreix Customer Block |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 8030 |
X-Powered-By: | W3 Total Cache/0.9.6 |
Accept-Ranges: | bytes |
Expires: | Wed, 25 Jul 2018 06:47:07 GMT |
Vary: | Accept-Encoding,Cookie |
Keep-Alive: | timeout=5, max=100 |
Server: | Apache |
Last-Modified: | Wed, 25 Jul 2018 05:47:07 GMT |
Connection: | Keep-Alive |
Pragma: | public |
Cache-Control: | max-age=1145, public |
Date: | Wed, 25 Jul 2018 06:28:02 GMT |
Content-Type: | text/html; charset=UTF-8 |
Content-Encoding: | gzip |
soa: | ns.mainnameserver.com. hostmaster.mainnameserver.com. 2018072066 10800 600 2419200 3600 |
txt: | "MS=ms26038905" "v=spf1 a mx include:_spf.simpology.uk.com include:spf.protection.outlook.com ip4:81.101.80.5/32 include:spf.mtaroutes.com -all" |
ns: | ns2.mainnameserver.com. ns.mainnameserver.com. |
ipv4: | IP:89.187.86.121 ASN:31708 OWNER:COREIX-UK-AS London, Great Britain, GB Country:GB |
mx: | MX preference = 30, mail exchanger = mx3-eu.mtaroutes.com. MX preference = 20, mail exchanger = mx2-eu.mtaroutes.com. MX preference = 10, mail exchanger = mx1-eu.mtaroutes.com. MX preference = 40, mail exchanger = mx4-eu.mtaroutes.com. |
contact : [email protected] about us technology pipeline competitive advantages news & events contact us enter search words and press enter oral administration triggers broad immunity thermostable delivery opens new markets standard manufacture creates savings competitive advantage prokarium ltd is a clinical stage sme with a dual business model: read more oral vaccine delivery prokarium’s oral vaccine delivery platform is designed to take an antigen from gene sequence to immune response... read more unmet medical needs prokarium is focused on chlamydia, clostridium difficile and copd/asthma, but is also pursuing r&d on other programmes... read more skip to content what makes us different unique value of prokarium’s vaccine platform triggers all arms of the immune system oral delivery simple, low-cost manufacture safe, immunogenic vector cold chain-free for final distribution stage no vector immunity our team dr steve chatfield chairman of the board dr carl-johan spak member of the board of directors on behalf of flerie invest dr allan p. jarvis member of the board of directors dr khalid al-saleh member of the board of directors on behalf of investor rvc mr sangwoo lee member of the board of directors on behalf of investor kip dr hakim (abdelhakim) hammach advisory board member dr ted fjällman chief executive officer peter coleman chief financial officer dr annelise soulier principal scientist dr rocky cranenburgh chief scientific officer dr ricardo moreira senior scientist dr mike darsley head of clinical development dr paola salerno principal scientist dr aindrias ryan senior scientist latest news & events prokarium moves into london bioscience innovation centre (lbic) 21st may 2018 - prokarium moves into new offices at the london bioscience innovation centre near kings cross station. "it is with pleasure that we read more prokarium is expanding and looking for new hires 12th march 2018 - on the back of recent investment, prokarium is expanding its team with several new positions. among the first hires will be read more prokarium secures $10 million investment from saudi, swedish and korean investors for clinical development of revolutionary thermostable vaccines keele, uk, riyadh, ksa, stockholm, se, and seoul, kr; 26th february 2018 - prokarium, the uk-based synthetic biology company that has developed vaxonella, an oral, read more financial times – uk’s life sciences sector is ambitious for the eu prokarium’s ceo ted fjallman was interviewed by the financial times’ science editor. read article on ft read more prokarium featured in labiotech – developing innovative oral vaccines a short report on prokarium by labiotech.eu, the leading digital media covering the european biotech industry, was published last in april 2017. read article on labiotech read more prokarium and probiomed in uk-mexico collaboration to scale-up manufacture of thermostable vaccines with a focus on diarrhoea keele, uk and mexico city, mx, 4th january 2017 prokarium and probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered read more prokarium © 2018
http://prokarium.com/team/members/peter-coleman/
http://prokarium.com/team/members/dr-rocky-cranenburgh/
http://prokarium.com/vaxonella-platform/
http://prokarium.com/team/members/dr-ricardo-moreira/
http://prokarium.com/team/members/dr-hakim-abdelhakim-hammach/
http://prokarium.com/team/members/dr-steve-chatfield/
http://prokarium.com/team/members/dr-paola-salerno/
http://prokarium.com/team/members/dr-carl-johan-spak/
http://prokarium.com/team/members/dr-annelise-soulier/
http://prokarium.com/vaxonella-platform
http://prokarium.com/team/members/dr-aindrias-ryan/
http://prokarium.com/competitive-advantages/
http://prokarium.com/contact-us/
http://prokarium.com/about-us/
http://prokarium.com/vaxonella-platform/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: PROKARIUM.COM
Registry Domain ID: 1568352215_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.meshdigital.com
Registrar URL: http://www.meshdigital.com
Updated Date: 2017-09-03T03:57:56Z
Creation Date: 2009-09-08T11:25:17Z
Registry Expiry Date: 2019-09-08T11:25:17Z
Registrar: Mesh Digital Limited
Registrar IANA ID: 1390
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.MAINNAMESERVER.COM
Name Server: NS2.MAINNAMESERVER.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-03-18T12:21:41Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Mesh Digital Limited
SERVERS
SERVER com.whois-servers.net
ARGS domain =prokarium.com
PORT 43
TYPE domain
DOMAIN
NAME prokarium.com
CHANGED 2017-09-03
CREATED 2009-09-08
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS.MAINNAMESERVER.COM 79.170.40.2
NS2.MAINNAMESERVER.COM 79.170.43.3
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .